David-alexandre A. Gross

Evry, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

CD8+ T cell activation occurs 24 hours after AAV administration and is driven by muscle promoter specificity.

CD8+ T cell activation occurs 24 hours after AAV administration and is driven by muscle promoter specificity.

Journal: JCI insight

Published: November 24, 2025

Identification of alterations of immunometabolism associated with Pompe disease.

Identification of alterations of immunometabolism associated with Pompe disease.

Journal: Cellular and molecular life sciences : CMLS

Published: August 20, 2025

Synergism of dual AAV gene therapy and rapamycin rescues GSDIII phenotype in muscle and liver.

Synergism of dual AAV gene therapy and rapamycin rescues GSDIII phenotype in muscle and liver.

Journal: JCI insight

Published: May 26, 2023

Muscle-specific, liver-detargeted adeno-associated virus gene therapy rescues Pompe phenotype in adult and neonate Gaa-/- mice.

Muscle-specific, liver-detargeted adeno-associated virus gene therapy rescues Pompe phenotype in adult and neonate Gaa-/- mice.

Journal: Journal of inherited metabolic disease

Published: December 21, 2022

Overcoming the Challenges Imposed by Humoral Immunity to AAV Vectors to Achieve Safe and Efficient Gene Transfer in Seropositive Patients.

Overcoming the Challenges Imposed by Humoral Immunity to AAV Vectors to Achieve Safe and Efficient Gene Transfer in Seropositive Patients.

Journal: Frontiers in immunology

Published: January 18, 2022

Of rAAV and Men: From Genetic Neuromuscular Disorder Efficacy and Toxicity Preclinical Studies to Clinical Trials and Back.

Of rAAV and Men: From Genetic Neuromuscular Disorder Efficacy and Toxicity Preclinical Studies to Clinical Trials and Back.

Journal: Journal of personalized medicine

Published: October 31, 2020

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors.

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors.

Journal: Frontiers in immunology

Published: January 30, 2020

Foxp3+ Regulatory and Conventional CD4+ T Cells Display Similarly High Frequencies of Alloantigen-Reactive Cells.

Foxp3+ Regulatory and Conventional CD4+ T Cells Display Similarly High Frequencies of Alloantigen-Reactive Cells.

Journal: Frontiers in immunology

Published: December 10, 2018

Cross-Presentation of Skin-Targeted Recombinant Adeno-associated Virus 2/1 Transgene Induces Potent Resident Memory CD8+ T Cell Responses.

Cross-Presentation of Skin-Targeted Recombinant Adeno-associated Virus 2/1 Transgene Induces Potent Resident Memory CD8+ T Cell Responses.

Journal: Journal of virology

Published: August 03, 2018

Induction of tumor-specific CTL responses using the C-terminal fragment of Viral protein R as cell penetrating peptide.

Induction of tumor-specific CTL responses using the C-terminal fragment of Viral protein R as cell penetrating peptide.

Journal: Scientific reports

Published: June 20, 2018

Correction: Depletion of Regulatory T Cells Induces High Numbers of Dendritic Cells and Unmasks a Subset of Anti-Tumour CD8+CD11c+ PD-1lo Effector T Cells.

Correction: Depletion of Regulatory T Cells Induces High Numbers of Dendritic Cells and Unmasks a Subset of Anti-Tumour CD8+CD11c+ PD-1lo Effector T Cells.

Journal: PloS one

Published: January 28, 2017

Intradermal Immunization with rAAV1 Vector Induces Robust Memory CD8+ T Cell Responses Independently of Transgene Expression in DCs.

Intradermal Immunization with rAAV1 Vector Induces Robust Memory CD8+ T Cell Responses Independently of Transgene Expression in DCs.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: October 12, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026